rs773820426
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_003238.6(TGFB2):c.493C>T(p.Arg165Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,613,854 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R165Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_003238.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFB2 | NM_003238.6 | c.493C>T | p.Arg165Trp | missense_variant | 2/7 | ENST00000366930.9 | NP_003229.1 | |
TGFB2 | NM_001135599.4 | c.577C>T | p.Arg193Trp | missense_variant | 3/8 | NP_001129071.1 | ||
TGFB2 | NR_138148.2 | n.1859C>T | non_coding_transcript_exon_variant | 2/7 | ||||
TGFB2 | NR_138149.2 | n.1943C>T | non_coding_transcript_exon_variant | 3/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGFB2 | ENST00000366930.9 | c.493C>T | p.Arg165Trp | missense_variant | 2/7 | 1 | NM_003238.6 | ENSP00000355897.4 | ||
TGFB2 | ENST00000366929.4 | c.577C>T | p.Arg193Trp | missense_variant | 3/8 | 1 | ENSP00000355896.4 | |||
TGFB2 | ENST00000488793.1 | n.157C>T | non_coding_transcript_exon_variant | 2/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152018Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251348Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135832
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461836Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 727218
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152018Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74236
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2024 | The p.R165W variant (also known as c.493C>T), located in coding exon 2 of the TGFB2 gene, results from a C to T substitution at nucleotide position 493. The arginine at codon 165 is replaced by tryptophan, an amino acid with dissimilar properties. This alteration was reported in one patient with syndromic heritable thoracic aortic disorder, but clinical details were limited (Campens L et al. Orphanet J Rare Dis. 2015;10:9). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Loeys-Dietz syndrome 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 19, 2023 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 165 of the TGFB2 protein (p.Arg165Trp). This variant is present in population databases (rs773820426, gnomAD 0.004%). This missense change has been observed in individuals with clinical features of TGFB2-related conditions (PMID: 25644172, 29392890; Invitae). ClinVar contains an entry for this variant (Variation ID: 408428). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TGFB2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 27, 2023 | Reported as p.(R193W) in an individual with syndromic TAAD and reported to segregate with disease in the family, although no additional clinical information was provided (Campens et al., 2015); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25644172, 29392890) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at